Suchergebnisse - "Kulabaş, Necla"

PubPharm (14)

1

Novel 1,2,4-triazoles derived from Ibuprofen : synthesis and in vitro evaluation of their mPGES-1 inhibitory and antiproliferative activity

enthalten in: Molecular diversity | 2023

von Bülbül, B. | Ding, K. | Zhan, C. | +13

2

Synthesis and standardization of an impurity of acetaminophen, development and validation of liquid chromatographic method

enthalten in: Journal of pharmaceutical and biomedical analysis | 2023

von Arıkan, C. | Kulabaş, N. | Küçükgüzel, �.

3

Synthesis, Molecular Docking Studies and ADME Prediction of Some New Albendazole Derivatives as α-Glucosidase Inhibitors

enthalten in: Acta chimica Slovenica | 2022

von Senkardes, S. | Kulabas, N. | Kucukguzel, S.

4

Synthesis and structure-activity relationship of L-methionine-coupled 1,3,4-thiadiazole derivatives with activity against influenza virus

enthalten in: Chemical biology & drug design | 2022

von Tatar, E. | Yaldız, S. | Kulabaş, N. | +3

5

Synthesis and structure–activity relationship of L‐methionine‐coupled 1,3,4‐thiadiazole derivatives with activity against influenza virus

enthalten in: Chemical Biology & Drug Design | 2022

von Tatar, E. | Yaldız, S. | Kulabaş, N. | +3

6

Novel fluoroquinolones containing 2‐arylamino‐2‐oxoethyl fragment : Design, synthesis, evaluation of antibacterial and antituberculosis activities and molecular modeling studies

enthalten in: Journal of Heterocyclic Chemistry | 2022

von Kulabaş, N. | Türe, A. | Bozdeveci, A. | +4

7

Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors

enthalten in: Molecular diversity | 2020

von Şenkardeş, S. | Han, M. | Kulabaş, N. | +4

8

Synthesis and Anticancer and Antimicrobial Evaluation of Novel Ether-linked Derivatives of Ornidazole

enthalten in: Turkish journal of pharmaceutical sciences | 2020

von Şenkardeş, S. | Kulabaş, N. | Bingöl Özakpinar, �. | +4

9

Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors

enthalten in: Molecular diversity | 2019

von Şenkardeş, S. | Han, M. | Kulabaş, N. | +4

10

Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors

enthalten in: Molecular diversity | 2019

von Şenkardeş, S. | Han, M. | Kulabaş, N. | +4